Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.38M Buy
246,500
+98,600
+67% +$3.12M ﹤0.01% 1680
2026
Q2
$3.85M Buy
147,900
+109,200
+282% +$3.31M ﹤0.01% 2382
2026
Q1
$1.08M Buy
38,700
+25,800
+200% +$657K ﹤0.01% 3202
2025
Q4
$253K Buy
+12,900
New +$272K ﹤0.01% 3902
2025
Q2
– Sell
-18,100
Closed -$298K – 3602
2025
Q1
$298K Buy
18,100
+1,100
+6% +$21.3K ﹤0.01% 2930
2024
Q4
$331K Sell
17,000
-1,300
-7% -$31.7K ﹤0.01% 2949
2024
Q3
$626K Buy
+18,300
New +$671K ﹤0.01% 2295

Other funds holding TRMD

IMC Chicago's TRMD Position: Q3 2026 in Review

IMC Chicago increased its TORM (TRMD) stake by 246% in Q3 2026, buying an estimated $1.97M and bringing the position to 87,548 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2636.

IMC Chicago first reported a position in TRMD in Q3 2024 and has held it in 5 quarters since. 88 funds tracked by Wall St. Rank hold TRMD as of Q3 2026.

  • IMC Chicago held 87,548 shares of TORM worth $3.33M as of Q3 2026.
  • IMC Chicago bought 62,273 TORM shares in Q3 2026, an estimated $1.97M.
  • TORM made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #2636 holding.
  • IMC Chicago first reported a position in TORM in Q3 2024 and has held it in 5 quarters since.
  • 88 funds tracked by Wall St. Rank held TORM as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.